“…In particularly, fluorescent nanoparticles (NPs) covalently linked with biorecognition ligands have shown great merits in cancer diagnosis and therapy 5, 6, 7, 8. As compared to molecular dye‐ligand conjugates, the multiple targeting ligands presented on NP surfaces allow multivalent recognition and binding to receptors on cell membrane, resulting in higher binding affinity and much improved selectivity toward targeted cells 9, 10, 11. With the rapid advances of nanotechnology, versatile NP systems including semiconducting quantum dots (QDs), gold NPs, and dye encapsulated NPs, etc., have been developed 12, 13, 14, 15, 16.…”